Development  ||| S:0 E:12 ||| NN
of  ||| S:12 E:15 ||| IN
Hf ||| S:15 E:17 ||| NNP
( ||| S:17 E:18 ||| -LRB-
4+ ||| S:18 E:20 ||| NNP
) ||| S:20 E:21 ||| -RRB-
-immobilized  ||| S:21 E:34 ||| JJ
polydopamine-coated  ||| S:34 E:54 ||| JJ
magnetic  ||| S:54 E:63 ||| JJ
graphene  ||| S:63 E:72 ||| NN
for  ||| S:72 E:76 ||| IN
highly  ||| S:76 E:83 ||| RB
selective  ||| S:83 E:93 ||| JJ
enrichment  ||| S:93 E:104 ||| NN
of  ||| S:104 E:107 ||| IN
phosphopeptides  ||| S:107 E:123 ||| NN
In  ||| S:123 E:126 ||| IN
this  ||| S:126 E:131 ||| DT
work ||| S:131 E:135 ||| NN
,  ||| S:135 E:137 ||| ,
we  ||| S:137 E:140 ||| PRP
first  ||| S:140 E:146 ||| RB
designed  ||| S:146 E:155 ||| VBN
and  ||| S:155 E:159 ||| CC
synthesized  ||| S:159 E:171 ||| VBG
an  ||| S:171 E:174 ||| DT
IMAC  ||| S:174 E:179 ||| NNP
material  ||| S:179 E:188 ||| NN
with  ||| S:188 E:193 ||| IN
Hf ||| S:193 E:195 ||| NNP
( ||| S:195 E:196 ||| -LRB-
4+ ||| S:196 E:198 ||| NNP
)  ||| S:198 E:200 ||| -RRB-
immobilized  ||| S:200 E:212 ||| NN
on  ||| S:212 E:215 ||| IN
polydopamine-coated  ||| S:215 E:235 ||| JJ
magnetic  ||| S:235 E:244 ||| JJ
graphene  ||| S:244 E:253 ||| NN
and  ||| S:253 E:257 ||| CC
applied  ||| S:257 E:265 ||| VBD
it  ||| S:265 E:268 ||| PRP
to  ||| S:268 E:271 ||| TO
phosphopeptides  ||| S:271 E:287 ||| VB
enrichment  ||| S:287 E:298 ||| VBN
successfully ||| S:298 E:310 ||| RB
.  ||| S:310 E:312 ||| .
The  ||| S:312 E:316 ||| DT
newly  ||| S:316 E:322 ||| RB
prepared  ||| S:322 E:331 ||| JJ
material  ||| S:331 E:340 ||| NN
gathered  ||| S:340 E:349 ||| VBD
the  ||| S:349 E:353 ||| DT
advantages  ||| S:353 E:364 ||| NNS
of  ||| S:364 E:367 ||| IN
large  ||| S:367 E:373 ||| JJ
specific  ||| S:373 E:382 ||| JJ
surface  ||| S:382 E:390 ||| NN
area  ||| S:390 E:395 ||| NN
of  ||| S:395 E:398 ||| IN
graphene ||| S:398 E:406 ||| NN
,  ||| S:406 E:408 ||| ,
good  ||| S:408 E:413 ||| JJ
hydrophilicity  ||| S:413 E:428 ||| NN
and  ||| S:428 E:432 ||| CC
biocompatibility  ||| S:432 E:449 ||| NN
of  ||| S:449 E:452 ||| IN
polydopamine  ||| S:452 E:465 ||| NN
and  ||| S:465 E:469 ||| CC
superparamagnetism  ||| S:469 E:488 ||| NN
of  ||| S:488 E:491 ||| IN
Fe3O4 ||| S:491 E:496 ||| CD
.  ||| S:496 E:498 ||| .
We  ||| S:498 E:501 ||| PRP
investigated  ||| S:501 E:514 ||| VBD
the  ||| S:514 E:518 ||| DT
performance  ||| S:518 E:530 ||| NN
of  ||| S:530 E:533 ||| IN
Hf ||| S:533 E:535 ||| NNP
( ||| S:535 E:536 ||| -LRB-
4+ ||| S:536 E:538 ||| NNP
) ||| S:538 E:539 ||| -RRB-
-immobilized  ||| S:539 E:552 ||| JJ
polydopamine-coated  ||| S:552 E:572 ||| JJ
magnetic  ||| S:572 E:581 ||| JJ
graphene  ||| S:581 E:590 ||| NNS
( ||| S:590 E:591 ||| -LRB-
denoted  ||| S:591 E:599 ||| NN
as  ||| S:599 E:602 ||| IN
magG ||| S:602 E:606 ||| JJ
@ ||| S:606 E:607 ||| IN
PDA-Hf ||| S:607 E:613 ||| NNP
( ||| S:613 E:614 ||| -LRB-
4+ ||| S:614 E:616 ||| NNP
) ||| S:616 E:617 ||| -RRB-
)  ||| S:617 E:619 ||| -RRB-
in  ||| S:619 E:622 ||| IN
phosphopeptides  ||| S:622 E:638 ||| JJ
enrichment  ||| S:638 E:649 ||| NN
and  ||| S:649 E:653 ||| CC
the  ||| S:653 E:657 ||| DT
results  ||| S:657 E:665 ||| NNS
showed  ||| S:665 E:672 ||| VBD
high  ||| S:672 E:677 ||| JJ
selectivity  ||| S:677 E:689 ||| NN
and  ||| S:689 E:693 ||| CC
sensitivity  ||| S:693 E:705 ||| NN
of  ||| S:705 E:708 ||| IN
the  ||| S:708 E:712 ||| DT
new  ||| S:712 E:716 ||| JJ
material ||| S:716 E:724 ||| NN
.  ||| S:724 E:726 ||| .
Finally ||| S:726 E:733 ||| RB
,  ||| S:733 E:735 ||| ,
we  ||| S:735 E:738 ||| PRP
successfully  ||| S:738 E:751 ||| RB
applied  ||| S:751 E:759 ||| VBN
magG ||| S:759 E:763 ||| JJ
@ ||| S:763 E:764 ||| IN
PDA-Hf ||| S:764 E:770 ||| NNP
( ||| S:770 E:771 ||| -LRB-
4+ ||| S:771 E:773 ||| NNP
)  ||| S:773 E:775 ||| -RRB-
to  ||| S:775 E:778 ||| TO
phosphopeptides  ||| S:778 E:794 ||| VB
enrichment  ||| S:794 E:805 ||| VBN
from  ||| S:805 E:810 ||| IN
non-fat  ||| S:810 E:818 ||| JJ
milk  ||| S:818 E:823 ||| NN
digests  ||| S:823 E:831 ||| NNS
and  ||| S:831 E:835 ||| CC
human  ||| S:835 E:841 ||| JJ
serum ||| S:841 E:846 ||| NN
,  ||| S:846 E:848 ||| ,
further  ||| S:848 E:856 ||| RB
demonstrating  ||| S:856 E:870 ||| VBG
excellent  ||| S:870 E:880 ||| JJ
performance  ||| S:880 E:892 ||| NN
of  ||| S:892 E:895 ||| IN
this  ||| S:895 E:900 ||| DT
new  ||| S:900 E:904 ||| JJ
material  ||| S:904 E:913 ||| NN
in  ||| S:913 E:916 ||| IN
phosphopeptides  ||| S:916 E:932 ||| JJ
enrichment ||| S:932 E:942 ||| NN
.  ||| S:942 E:944 ||| .
